Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 150


Adenosine Induces EBV Lytic Reactivation through ADORA1 in EBV-Associated Gastric Carcinoma.

Choi SJ, Ryu E, Lee S, Huh S, Shin YS, Kang BW, Kim JG, Cho H, Kang H.

Int J Mol Sci. 2019 Mar 14;20(6). pii: E1286. doi: 10.3390/ijms20061286.


Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma.

Park JS, Oh Y, Park YJ, Park O, Yang H, Slania S, Hummers LK, Shah AA, An HT, Jang J, Horton MR, Shin J, Dietz HC, Song E, Na DH, Park EJ, Kim K, Lee KC, Roschke VV, Hanes J, Pomper MG, Lee S.

Nat Commun. 2019 Mar 8;10(1):1128. doi: 10.1038/s41467-019-09101-4.


Enhanced photocatalytic degradation of lindane using metal-semiconductor Zn@ZnO and ZnO/Ag nanostructures.

Jung HJ, Koutavarapu R, Lee S, Kim JH, Choi HC, Choi MY.

J Environ Sci (China). 2018 Dec;74:107-115. doi: 10.1016/j.jes.2018.02.014. Epub 2018 Mar 3.


Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK.

Lee S, Cho YY, Cho EJ, Yu SJ, Lee JH, Yoon JH, Kim YJ.

Int J Mol Med. 2018 Nov;42(5):2551-2559. doi: 10.3892/ijmm.2018.3807. Epub 2018 Aug 3.


Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease.

Kim D, Yoo JM, Hwang H, Lee J, Lee SH, Yun SP, Park MJ, Lee M, Choi S, Kwon SH, Lee S, Kwon SH, Kim S, Park YJ, Kinoshita M, Lee YH, Shin S, Paik SR, Lee SJ, Lee S, Hong BH, Ko HS.

Nat Nanotechnol. 2018 Sep;13(9):812-818. doi: 10.1038/s41565-018-0179-y. Epub 2018 Jul 9.


The c-Abl inhibitor, Radotinib HCl, is neuroprotective in a preclinical Parkinson's disease mouse model.

Lee S, Kim S, Park YJ, Yun SP, Kwon SH, Kim D, Kim DY, Shin JS, Cho DJ, Lee GY, Ju HS, Yun HJ, Park JH, Kim WR, Jung EA, Lee S, Ko HS.

Hum Mol Genet. 2018 Jul 1;27(13):2344-2356. doi: 10.1093/hmg/ddy143.


Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson's disease.

Yun SP, Kam TI, Panicker N, Kim S, Oh Y, Park JS, Kwon SH, Park YJ, Karuppagounder SS, Park H, Kim S, Oh N, Kim NA, Lee S, Brahmachari S, Mao X, Lee JH, Kumar M, An D, Kang SU, Lee Y, Lee KC, Na DH, Kim D, Lee SH, Roschke VV, Liddelow SA, Mari Z, Barres BA, Dawson VL, Lee S, Dawson TM, Ko HS.

Nat Med. 2018 Jul;24(7):931-938. doi: 10.1038/s41591-018-0051-5. Epub 2018 Jun 11.


Transforming growth factor-β decreases side population cells in hepatocellular carcinoma in vitro.

Kim JB, Lee S, Kim HR, Park SY, Lee M, Yoon JH, Kim YJ.

Oncol Lett. 2018 Jun;15(6):8723-8728. doi: 10.3892/ol.2018.8441. Epub 2018 Apr 5.


High-fluence 1064-nm Q-Switched Nd:YAG laser: Safe and effective treatment of café-au-lait macules in Asian patients.

Baek JO, Park IJ, Lee KR, Ryu HR, Kim J, Lee S, Kim YR, Hur H.

J Cosmet Dermatol. 2018 Jun;17(3):380-384. doi: 10.1111/jocd.12432. Epub 2018 May 3.


Molecularly Targeted MR Imaging Agent in Liver Fibrosis: High Sensitivity and Low Gadolinium Mean High Translational Potential.

Pomper MG, Lee S.

Radiology. 2018 May;287(2):590-591. doi: 10.1148/radiol.2018180084. No abstract available.



Soo Suk J, Suh J, Cui H, Kim AJ, Lee S, Yeo Y.

J Control Release. 2017 Dec 10;267:1. doi: 10.1016/j.jconrel.2017.11.014. No abstract available.


PEGylated TRAIL ameliorates experimental inflammatory arthritis by regulation of Th17 cells and regulatory T cells.

Park JS, Oh Y, Park O, Foss CA, Lim SM, Jo DG, Na DH, Pomper MG, Lee KC, Lee S.

J Control Release. 2017 Dec 10;267:163-171. doi: 10.1016/j.jconrel.2017.10.004. Epub 2017 Oct 7.


Nano-sized metabolic precursors for heterogeneous tumor-targeting strategy using bioorthogonal click chemistry in vivo.

Lee S, Jung S, Koo H, Na JH, Yoon HY, Shim MK, Park J, Kim JH, Lee S, Pomper MG, Kwon IC, Ahn CH, Kim K.

Biomaterials. 2017 Dec;148:1-15. doi: 10.1016/j.biomaterials.2017.09.025. Epub 2017 Sep 18.


In vivo stem cell tracking with imageable nanoparticles that bind bioorthogonal chemical receptors on the stem cell surface.

Lee S, Yoon HI, Na JH, Jeon S, Lim S, Koo H, Han SS, Kang SW, Park SJ, Moon SH, Park JH, Cho YW, Kim BS, Kim SK, Lee T, Kim D, Lee S, Pomper MG, Kwon IC, Kim K.

Biomaterials. 2017 Sep;139:12-29. doi: 10.1016/j.biomaterials.2017.05.050. Epub 2017 Jun 1.


3-bromopyruvate and buthionine sulfoximine effectively kill anoikis-resistant hepatocellular carcinoma cells.

Lee M, Jo A, Lee S, Kim JB, Chang Y, Nam JY, Cho H, Cho YY, Cho EJ, Lee JH, Yu SJ, Yoon JH, Kim YJ.

PLoS One. 2017 Mar 31;12(3):e0174271. doi: 10.1371/journal.pone.0174271. eCollection 2017.


The anti-HSV-1 effect of quercetin is dependent on the suppression of TLR-3 in Raw 264.7 cells.

Lee S, Lee HH, Shin YS, Kang H, Cho H.

Arch Pharm Res. 2017 May;40(5):623-630. doi: 10.1007/s12272-017-0898-x. Epub 2017 Mar 3.


Cathepsin B-Specific Metabolic Precursor for In Vivo Tumor-Specific Fluorescence Imaging.

Shim MK, Yoon HY, Ryu JH, Koo H, Lee S, Park JH, Kim JH, Lee S, Pomper MG, Kwon IC, Kim K.

Angew Chem Int Ed Engl. 2016 Nov 14;55(47):14698-14703. doi: 10.1002/anie.201608504. Epub 2016 Oct 20.


Anti-Cancer Effect of Quercetin in Xenograft Models with EBV-Associated Human Gastric Carcinoma.

Lee HH, Lee S, Shin YS, Cho M, Kang H, Cho H.

Molecules. 2016 Sep 26;21(10). pii: E1286.

Supplemental Content

Loading ...
Support Center